MYCOF Stock: Noveris Health Sciences Inc. Stock Price, Analysis & Insights
Get live MYCOF stock price $2.00, comprehensive Noveris Health Sciences Inc. stock analysis, charts, news, and expert forecast. Real-time MYCOF stock data and investment insights.
Loading chart data...
Noveris Health Sciences Inc. (MYCOF) Overview
Noveris Health Sciences Inc. (MYCOF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Pharmaceuticals industry . As of the latest trading session, MYCOF trades at $2.00 with a market capitalization of 117.10M . Over the past 52 weeks, MYCOF has traded between $0.03 and $2.04 , with the current price positioned at approximately 98% of this range . The sto...
Key Takeaways
- Operates in the Healthcare sector (Medical - Pharmaceuticals)
- Market cap: 117.10M
- Current price: $2.00
- 52-week range: $0.03 - $2.04
- P/E ratio: 1.11
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on Septemb...
Company Information
- CEO
- Jason Birmingham
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Employees
- 3
Contact Information
- Website
- https://www.mydecine.com
- Address
- 789 West Pender Street
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 1.1)
✓ Lower volatility stock (Beta: -5.48) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Noveris Health Sciences Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Noveris Health Sciences Inc.
- ⚠Investors should consider how Noveris Health Sciences Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
117.10M
P/E Ratio (TTM)
1.11
Beta
-5.48
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MYCOF with peer companies:
- Price
- $0.07
- Market cap
- 758.02K
- Price
- $0.12
- Market cap
- 3.41M
- Price
- $0.00
- Market cap
- 6.55K
- Price
- $0.05
- Market cap
- 3.83M
- Price
- $0.04
- Market cap
- 13.15M
- Price
- $0.00
- Market cap
- 6.87K
- Price
- $8.58
- Market cap
- 9.72M
- Price
- $0.03
- Market cap
- 5.24M
- Price
- $0.57
- Market cap
- 31.16M
- Price
- $0.00
- Market cap
- 9.87K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.